OPKO HealthMEX:OPK 53 Market Cap is MXN17,859 Mil as of Jul. 12, 2026. GuruFocus rates MEX:OPK with a GF Score™ of 53/100 and a GF Value™ of MXN19.16 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 217 Medical Diagnostics & Research companies, OPKO Health ranks better than 76.5% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). OPKO Health's share price for the quarter that ended in Mar. 2026 was MXN21. OPKO Health's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 755 Mil. Therefore, OPKO Health's market cap for the quarter that ended in Mar. 2026 was MXN15,857 Mil.
OPKO Health's quarterly market cap
declined
from Sep. 2025 (MXN19,218 Mil) to Dec. 2025 (MXN18,415 Mil) and
declined
from Dec. 2025 (MXN18,415 Mil) to Mar. 2026 (MXN15,857 Mil).
OPKO Health's annual market cap
increased
from Dec. 2023 (MXN19,587 Mil) to Dec. 2024 (MXN21,973 Mil) but then
declined
from Dec. 2024 (MXN21,973 Mil) to Dec. 2025 (MXN18,415 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OPKO Health's Enterprise Value for Today is MXN18,823 Mil.
OPKO Health (MEX:OPK) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
OPKO Health Market Cap Related Terms
OPKO Health Market Cap Historical Data
* Premium members only.
The historical data trend for OPKO Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:OPK vs PSNL, CDNA, CSTL: Market Cap Comparison
For the Diagnostics & Research subindustry, OPKO Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OPKO Health Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Market Cap distribution charts can be found below:
* The bar in red indicates where OPKO Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
OPKO Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPKO Health (MEX:OPK) has a Market Cap of MXN17,859 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OPKO Health and its competitors. According to the industry distribution chart, OPKO Health ranks #51 out of 217 companies in the Medical Diagnostics & Research industry, placing it in the top 23.5%.
Is OPKO Health's Market Cap too high?
OPKO Health's current Market Cap is MXN17,859 Mil. Based on the distribution chart, OPKO Health ranks #51 out of 217 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, OPKO Health has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Market Cap compare to PSNL and CDNA?
According to the Medical Diagnostics & Research industry distribution chart, OPKO Health ranks #51 out of 217 companies for Market Cap. This places OPKO Health in the top 24% of its industry — outperforming the majority of peers. The industry median Market Cap is 61.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 61.65, based on 217 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OPKO Health and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 61.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OPKO Health's current Market Cap is MXN17,859 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (MEX:OPK) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN19.16, compared to a current price of MXN26.20 — trading 36.7% above its estimated fair value. The current Market Cap is MXN17,859 Mil. OPKO Health's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For OPKO Health (MEX:OPK), the current Market Cap is MXN17,859 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OPKO Health (MEX:OPK) Overvalued in 2026?
Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued.
The current stock price of MXN26.20 is trading 36.7% above its estimated GF Value™ of MXN19.16.
GuruFocus considers OPKO Health to be Significantly Overvalued.
Key valuation signals for MEX:OPK:
Market Cap: MXN17,859 Mil
GF Value™: MXN19.16 vs. price of MXN26.20 (36.7% above fair value)
No single metric tells the full story. See the MEX:OPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
53GF Score
Get the complete analysis for MEX:OPK
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:OPK has been successfully added to your 
